iOMEDICO AG
Industry / private company
Location:
Freiburg,
Germany (DE)
ISNI: -
ROR: https://ror.org/03j5af397
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO) (2017)
Sehouli J, Tome O, Dimitrova D, Camara O, Runnebaum IB, Tessen HW, Rautenberg B, et al.
Journal article
Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma: Data from the German prospective RCC-Registry (2017)
Staehler M, Mueller L, Goebell P, Overkamp F, Frank M, Kruggel L, Jaenicke M, Marschner N
Conference contribution
Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma - data from the German prospective RCC-Registry (2017)
Staehler M, Goebell P, Mueller L, Overkamp F, Frank M, Kruggel L, Jaenicke M, Marschner N
Conference contribution
Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape (2017)
Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al.
Conference contribution
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study (2016)
Goebell P, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015)
Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al.
Journal article
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (2014)
Goebell P, Muench A, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article